Welcome to POP Research
Some students have concrete ideas about their specialty before they join our graduate program, but some do not or gain a better understanding after they have had more in-depth exposure. The selection of a concentration area should be based upon individual student interests and future career and research goals. The areas of concentration in the Department’s graduate program are:
- Pharmacoepidemiology and Safety Sciences: Applies epidemiologic reasoning, methods, and knowledge to studies that examine the safety, effectiveness, and quality of drugs in human populations as well as healthcare systems that impact medication use. Examples of areas of research interest include drug safety, comparative effectiveness, drug utilization, and quality measures for medication safety and appropriateness. Learn more.
- Pharmacoeconomics and Outcomes Research: assesses the value (clinical and economic) of pharmaceutical products and related services in the delivery of healthcare. It aims to provide patients, providers, and payers with evidence to inform decision making. Important research areas include economic evaluations, budget impact analysis, multi-criteria decision analysis, and policy evaluations related to drug formulary, reimbursement, and pricing. Learn more.
- Pharmaceutical Health Services Research: Establishes the ability to evaluate the quality of medication use and medication use systems, to develop target interventions for identified quality deficits, and to evaluate the safety and effectiveness of such interventions. Examples of research include the development and validation of quality measures, or the implementation and evaluation of quality improvement programs. Learn more.
The University of Florida College of Pharmacy Department of Pharmaceutical Outcomes and Policy offers a STEM-designated Ph.D. program in Pharmaceutical Sciences with a concentration in Pharmaceutical Outcomes and Policy Research (POP Ph.D.). This program has the Department of Education’s Classification of Instructional Program, or CIP, taxonomy code CIP 51.2010. This code denotes Pharmaceutical Sciences and is a STEM-designated degree program.
Students are admitted into the Ph.D. and residential M.S. programs in the fall semester. Review of applications begins December 1 and ends April 1. Decisions on first round interviews and nominations for fellowship are finalized by January 15; thus completing your application before December 1 is strongly encouraged. The online M.S. programs offer rolling admission.